Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Hi-Tech Pharmacal Co Inc (HITK)

NASDAQ
Currency in USD
Disclaimer
43.49
0.00(0.00%)
Real-time Data
HITK Scorecard
Fair Value
Day's Range
43.4943.50
52 wk Range
0.0043.50
Prev. Close
43.49
Open
43.5
Day's Range
43.49-43.5
52 wk Range
0-0
Volume
0
Average Vol. (3m)
176,757
1-Year Change
-0.01%
Shares Outstanding
13,907,000
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about HITK?
Vote to see community's results!
or

Hi-Tech Pharmacal Co Inc Company Profile

Hi-Tech Pharmacal Co., Inc. operates as a specialty pharmaceutical company that develops, manufactures, and markets generic and branded prescription, and over-the-counter (OTC) products in the United States. It operates in three segments: Generic Pharmaceuticals, OTC Branded Pharmaceuticals, and Prescription Brands. The company manufactures liquid and semi-solid dosage forms; and produces a range of sterile ophthalmic, otic, and inhalation products. Its generic products include oral solutions and suspensions, topical creams, and ointments, as well as nasal sprays. Hi-Tech Pharmacal Co. also markets OTC branded products, such as Diabetic Tussin, DiabetiDerm, Multi-betic, Mag-Ox, Choice DM, and DiabetiSweet primarily for people with diabetes; capsaicin products under the Zostrix brand name for pain management of conditions comprising arthritis and foot pain; Nasal Ease homeopathic allergy reliever; and Sinus Buster homeopathic sinus congestion reliever. In addition, the company markets and distributes branded prescription products to treat various disease states, including pain, cough/cold and allergies, contact dermatitis, sleep disorders, and swimmer’s ear. It serves chain drug stores, drug wholesalers, managed care purchasing organizations, federal government agencies, generic distributors, mass merchandisers, and mail order pharmacies. Hi-Tech Pharmacal Co., Inc. was founded in 1982 and is headquartered in Amityville, New York. As of April 17, 2014, Hi-Tech Pharmacal Co., Inc. operates as a subsidiary of Akorn Operating Company LLC.

Employees
448
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.